Private Advisor Group LLC Has $1.11 Million Stake in Humana Inc. (NYSE:HUM)

Private Advisor Group LLC raised its position in shares of Humana Inc. (NYSE:HUM) by 45.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,966 shares of the insurance provider’s stock after buying an additional 925 shares during the period. Private Advisor Group LLC’s holdings in Humana were worth $1,108,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of HUM. Avantax Advisory Services Inc. increased its holdings in shares of Humana by 12.2% during the fourth quarter. Avantax Advisory Services Inc. now owns 2,446 shares of the insurance provider’s stock worth $1,120,000 after buying an additional 265 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in shares of Humana by 8.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,970 shares of the insurance provider’s stock valued at $3,649,000 after purchasing an additional 594 shares in the last quarter. Brown Advisory Inc. increased its holdings in shares of Humana by 17.9% in the fourth quarter. Brown Advisory Inc. now owns 2,724 shares of the insurance provider’s stock valued at $1,247,000 after purchasing an additional 413 shares in the last quarter. Norges Bank acquired a new stake in shares of Humana in the fourth quarter valued at approximately $676,800,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Humana in the fourth quarter valued at approximately $1,062,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 0.9 %

HUM opened at $321.56 on Monday. The stock has a market capitalization of $38.72 billion, a P/E ratio of 20.02, a P/E/G ratio of 2.56 and a beta of 0.50. Humana Inc. has a 12 month low of $298.61 and a 12 month high of $530.54. The firm’s fifty day simple moving average is $364.11 and its 200 day simple moving average is $346.85. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $8.94 EPS. As a group, research analysts anticipate that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.10%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Bank of America raised their price target on shares of Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a report on Monday, May 20th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 target price on shares of Humana in a report on Tuesday, September 10th. Truist Financial lifted their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. Finally, Baird R W raised shares of Humana to a “hold” rating in a report on Thursday, May 30th. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $398.70.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.